These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23416019)

  • 1. Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol.
    Kida K; Yoneyama K; Kobayashi Y; Takano M; Akashi YJ; Miyake F
    Int J Cardiol; 2013 Sep; 168(2):1588-9. PubMed ID: 23416019
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to editor: Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol.
    Sarli B; Celik T; Kaya MG
    Int J Cardiol; 2013 Oct; 168(3):3134-5. PubMed ID: 23628294
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to the letter regarding the article, "late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol".
    Kida K; Yoneyama K; Kobayashi Y; Takano M; Akashi YJ; Miyake F
    Int J Cardiol; 2013 Oct; 168(4):4351. PubMed ID: 23725816
    [No Abstract]   [Full Text] [Related]  

  • 4. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
    Bello D; Shah DJ; Farah GM; Di Luzio S; Parker M; Johnson MR; Cotts WG; Klocke FJ; Bonow RO; Judd RM; Gheorghiade M; Kim RJ
    Circulation; 2003 Oct; 108(16):1945-53. PubMed ID: 14557364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol produces sustained long-term benefits: follow-up at 12 years.
    MacGregor JF; Wachter SB; Munger M; Stoddard G; Bristow MR; Gilbert EM
    Congest Heart Fail; 2009; 15(1):5-8. PubMed ID: 19187400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
    Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis.
    Schleman KA; Lindenfeld JA; Lowes BD; Bristow MR; Ferguson D; Wolfel EE; Abraham WT; Zisman LS
    J Card Fail; 2001 Mar; 7(1):4-12. PubMed ID: 11264544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol.
    Mukai Y; Yoshida T; Nakaike R; Mukai N; Iwato K; Kyo T; Kaseda S
    Intern Med; 2004 Nov; 43(11):1087-8. PubMed ID: 15609710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial dysfunction: hibernation and remodelling.
    Köszegi Z; Balogh E
    Lancet; 2003 Oct; 362(9393):1416-7; author reply 1417. PubMed ID: 14585649
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.
    Bradham WS; Bell SP; Adkisson DW; Smith HM; Harrell FE; Lawson MA; Ooi H; Sawyer DB; Kronenberg MW
    J Card Fail; 2017 Mar; 23(3):262-265. PubMed ID: 27940336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case studies in heart failure.
    Paul S; Trupp RJ
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):519-23, x. PubMed ID: 14717398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle.
    Giardini A; Lovato L; Donti A; Formigari R; Gargiulo G; Picchio FM; Fattori R
    Int J Cardiol; 2007 Jan; 114(2):241-6. PubMed ID: 21882492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P; Broadhurst P; Lahiri A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.